Open Access. Powered by Scholars. Published by Universities.®
Chemical and Pharmacologic Phenomena Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Education (3)
- Medical Pharmacology (3)
- Medical Specialties (2)
- Translational Medical Research (2)
- Behavioral Medicine (1)
-
- Chemicals and Drugs (1)
- Critical Care (1)
- Demography, Population, and Ecology (1)
- Emergency Medicine (1)
- Hepatology (1)
- Inequality and Stratification (1)
- Medical Humanities (1)
- Medical Toxicology (1)
- Mental and Social Health (1)
- Other Chemicals and Drugs (1)
- Other Medical Sciences (1)
- Pharmaceutical Preparations (1)
- Pharmacy Administration, Policy and Regulation (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Primary Care (1)
- Race and Ethnicity (1)
- Social and Behavioral Sciences (1)
- Sociology (1)
- Substance Abuse and Addiction (1)
- Keyword
-
- ACE inhibitor (1)
- African american (1)
- Alafenamide (1)
- Angioedema (1)
- Angiotensin-converting enzyme inhibitor (1)
-
- Asian (1)
- Chronic (1)
- Disoproxil (1)
- Disparity (1)
- Factor Xa inhibitor reversal (1)
- Hepatitis b (1)
- Icatibant (1)
- Intracranial hemorrhage (1)
- Kidney damage (1)
- Kidney function (1)
- Medication toxicity (1)
- Nephrotoxicity (1)
- Racial difference (1)
- Relapse (1)
- Renal (1)
- Substance Abuse (1)
- Tenofovir (1)
- Viral (1)
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Chemical and Pharmacologic Phenomena
Substance Abuse Relapse Is Not About Willpower But Is The Culmination Of Psychological And Socioeconomic Stress, Paul A. Steffes
Substance Abuse Relapse Is Not About Willpower But Is The Culmination Of Psychological And Socioeconomic Stress, Paul A. Steffes
Clinical Research in Practice: The Journal of Team Hippocrates
The author reflects on the impact of non-judgmental listening on patient care outcomes.
Renal Safety And Racial Disparity In Patients On Antiviral Treatment For Chronic Hepatitis B, Matthew Miller, Sindhuri Benjaram, Raya Kutaimy, Paul Naylor, Elizabeth May, Murray Ehrinpreis, Milton Mutchnick
Renal Safety And Racial Disparity In Patients On Antiviral Treatment For Chronic Hepatitis B, Matthew Miller, Sindhuri Benjaram, Raya Kutaimy, Paul Naylor, Elizabeth May, Murray Ehrinpreis, Milton Mutchnick
Medical Student Research Symposium
Background:
Many African Americans (AA) are chronically infected with Hepatitis B (HBV). While antiviral therapy is highly effective, clinical trials suggest a treatment-related decline in kidney function is possible. Given that chronic HBV predominately affects Asians worldwide, most studies have contained few AA patients. We evaluated these treatment-related kidney function changes in our predominately AA patient population.
Methods:
From 225 HBV patients, we identified 42 patients who were not co-infected with HIV or HCV, had a recent visit, and at least one earlier visit (before Jan 2017). If on treatment with antivirals it must have been for at least 2 …
Andexanet Alfa Is An Effective Reversal Agent For Factor Xa Inhibitors In Patients That Develop Intracranial Hemorrhage, Joseph Friedli
Andexanet Alfa Is An Effective Reversal Agent For Factor Xa Inhibitors In Patients That Develop Intracranial Hemorrhage, Joseph Friedli
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Connolly SJ, Milling TJ, Eikelboom JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131-1141. doi: 10.1056/NEJMoa1607887.
Icatibant Is Not Helpful For The Treatment Of Ace Inhibitor-Induced Angioedema, Samantha R. Schwartz
Icatibant Is Not Helpful For The Treatment Of Ace Inhibitor-Induced Angioedema, Samantha R. Schwartz
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Sinert R, Levy P, Bernstein JA, et al. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema. J Allergy Clin Immunol Pract. 2017; 5(5): 1402-1409. doi: 10.1016/j.jaip.2017.03.003.